It’s been a weird year for biotech stocks. One major index peaked in February, but since then, it’s been a slow downhill trudge for nearly every company. Some of the factors influencing the stock market as a whole have very little to do with biotech. But some financial trends really will matter for the industry.
Here are three basic forces that shaped the financial landscape for the biotech sector in 2021 — and why those same forces will drive the markets in 2022.
Lots of money is available for biotech companies …
More money than ever before has flooded into biotech venture capital firms. All that money will make its way into startups over the next five years or so, which means early-stage companies could continue to see extremely high levels of interest.
About the Author Reprints
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.